A federal judge rejected claims that the three largest US opioid distributors ignored warning signs when they sent millions of pills to a West Virginia community, handing a rare trial win for companies linked to the drug epidemic.
US District Judge David Faber said in an opinion Monday McKesson Corp.,
The judge concluded the local governments didn’t prove the distributors failed to put in place “effective controls” against opioids being diverted to illegal uses and couldn’t properly hold the companies accountable for billions of dollars in harms tied to the painkillers under state law.
“The opioid crisis has taken a considerable toll on the citizens of Cabell County and the City of Huntington,” Faber wrote in his 184-page ruling. “And while there is a natural tendency to assign blame in such cases, they must be decided not based on sympathy, but on the facts and the law.”
West Virginia has been among the hardest-hit states in the opioid epidemic, with Cabell County’s overdose death rate more than five times the national average during the period covered by the suit, according to researchers. West Virginia officials opted out of a settlement with the distributors last year, arguing it didn’t provide for their local governments still battling the scourge.
In that settlement,
“Pharmaceutical distributors like AmerisourceBergen have been asked to walk a legal and ethical tightrope between providing access to necessary medications and acting to prevent diversion of controlled substances,” Gabriel Weissman, a company spokesman, said in a statement. “Today’s ruling will help enable our company to do what we do best -- ensuring that health care facilities like hospitals and community pharmacies have access to the medications that patients and care providers need.”
Faber’s ruling reinforces arguments Cardinal Health’s lawyers made, Eric Timmerman, a company spokesman, said in a statement. The judge found the firm properly provides a “secure channel to deliver medications of all kinds from manufacturers to our thousands of hospital and pharmacy customers that dispense them to their patients based on doctor-ordered prescriptions.”
McKesson officials acknowledge prescription-drug abuse is a continuing issue, so they maintain “strong programs designed to detect and prevent opioid diversion within the pharmaceutical supply chain,” David Matthews, a company spokesman, said in an email.
Most of the remaining suits accuse companies across the opioid supply chain of creating public nuisances through their marketing efforts, supply and sale of the painkillers. That legal theory normally is invoked in property or pollution disputes. The next trial of claims by West Virginia cities and counties against the distributors is set to start July 5 in state court.
Faber’s ruling follows decisions by state-court judges in California and Oklahoma, who also rebuffed public-nuisance claims. However, juries that heard cases have backed nearly identical allegations in New York state court against opioid maker
In the Cabell County case, lawyers argued the distributors ignored warning signs about excessive opioid orders from West Virginia pharmacies.
“This case was always about holding these distributors accountable and providing our doctors, nurses, counselors, first responders and social workers with some of the resources needed to combat the opioid crisis,” Huntington Mayor
The companies said the real root of the opioid epidemic plaguing the West Virginia municipalities are illegal drugs brought in by gangs and not prescription pills diverted from legal shipments. They also argued expanding public nuisance laws to pharmaceutical disputes was inappropriate under the state’s laws.
“We are deeply disappointed personally and for the citizens of Cabell County and the city of Huntington,” lawyers for the West Virginia local governments said in a statement. “We felt the evidence that emerged from witness statements, company documents, and extensive datasets showed these defendants were responsible for creating and overseeing the infrastructure that flooded West Virginia with opioids.”
(Updates with McKesson comment in ninth paragraph)
To contact the reporter on this story:
To contact the editors responsible for this story:
Steve Stroth, Peter Jeffrey
© 2022 Bloomberg L.P. All rights reserved. Used with permission.